Primary Record
Clazosentan
- In stock
- 6,128 g
- Purity
- 98.8 %
- CAS
- 180384-56-9
Compound Identifiers & Properties
- CAS
- 180384-56-9
- PubChem CID
- 6433095
- SMILES
- CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
- Canonical SMILES
- COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO
Names & Synonyms
- Clazosentan
- Pivlaz
- clazosentanum
- 180384-56-9
- Clazosentan [INN]
- VML-588
- AXV-034343
- CLAZOSENTAN [MI]
- RefChem:577700
- VML 588
- Ro-61-1790
- AXV-343434
- Clazosentan (USAN/INN)
- Clazosentan [USAN:INN]
- CLAZOSENTAN [USAN]
- D0H2RJ
- Ro 61-1790
- UNII-3DRR0X4728
- AC1O5FK3
- AXV 034
- AXV-034
- DTXSID60170955
- CHEMBL109648
- VML588
- 3DRR0X4728
- CLAZOSENTAN [WHO-DD]
- ACT-108475
- orb1685955
- SCHEMBL1652657
- SCHEMBL1983603
- DTXCID3093446
- SCHEMBL29379450
- SCHEMBL29565931
- SCHEMBL29581324
- SCHEMBL29706388
- 1,3-benzodioxole-4-carbaldehyde
- CTK4D7597
- GTPL12286
- AXV343434
- LFWCJABOXHSRGC-UHFFFAOYSA-N
- GLXC-02568
- AXV 034343
- WHO 8397
- ZINC3939238
- AXV034343
- BDBM50066370
- EX-A10533
- AXV 343434
- CID6433095
- compound 22 [PMID: 9703472]
- DB06677
- SB18855
- CID:6433095
- AC-37936
- BC162764
- HY-17352
- MS-30385
- SID:53790501
- DB-065318
- J915.266K
- CS-0006250
- FT-0765561
- NS00069622
- D11664
- D85521
- C109641
- 2-Pyridinesulfonamide, N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)-4-pyridinyl]-4-pyrimidinyl]-5-methyl-
- A1246478
- N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
- Q1099339
- N-(6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- N-(2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- 2-PYRIDINESULFONAMIDE, N-(6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-2-(2-(1H-TETRAZOL-5-YL)-4-PYRIDINYL)-4-PYRIMIDINYL)-5-METHYL-
- 5-Methyl-pyridine-2-sulfonic acid {6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-2-[2-(2H-tetrazol-5-yl)-pyridin-4-yl]-pyrimidin-4-yl}-amide
- N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(2H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- N-[2-[2-(1H-Tetrazol-5-yl)-4-pyridyl]-5-(2-methoxyphenoxy)-6-(2-hydroxyethoxy)pyrimidin-4-yl]-5-methyl-2-pyridinesulfonamide
- N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(1H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
- N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(1H-tetrazole-5-yl)-4-pyridinyl]-4-pyrimidinyl]-5-methyl-2-pyridinesulfonamide
- N-[6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-2-[2-(2H-TETRAZOL-5-YL)(PYRIDIN-4-YL)]PYRIMIDIN-4-YL]-5-METHYL-PYRIDINE-2-SULFONAMIDE
- N-[6-(2-HYDROXYETHOXY)-5-(2-METHOXYPHENOXY)-2-[2-(2H-TETRAZOL-5-YL)-4-PYRIDINYL]-4-PYRIMIDINYL]-5-METHYL-2-PYRIDINESULFONAMIDE
- N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide
- N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamideAXV034
- N-{6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-(1H-tetrazol-5-yl)pyridin-4-yl)pyrimidin-4-yl}-5-methylpyridine-2-sulfonamide
- N-{6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl}-5-methylpyridine-2-sulfonamide